[1]
N. Jia, “Evaluating the Efficacy of Immune Checkpoint Inhibitors Across Different Cancer Types: Focusing on Lung Cancer, Breast Cancer and Melanoma”, TMBLS, vol. 8, pp. 39–44, Oct. 2025, doi: 10.62051/8hkm3p85.